Abnormal glucose metabolism in patients with Fontan circulation: Unique characteristics and associations with Fontan pathophysiology - 07/11/19
, Jun Negishi, MD a, Yosuke Hayama, MD a, Hikari Miike, MD a, Dai Suzuki, MD a, Kimiko Nakajima, MD a, Nao Konagai, MD a, Toru Iwasa, MD a, Heima Sakaguchi, MD, PhD a, Kenichi Kurosaki, MD a, Michikazu Nakai, PhD cAbstract |
Background |
Fontan patients exhibit a high prevalence of abnormal glucose metabolism (AGM). We aimed to characterize AGM and clarify its association with Fontan pathophysiology.
Methods |
We prospectively evaluated AGM with plasma glucose dynamics [mg/dL; fasting glucose (FPG), and maximum glucose increase (PG-spike)] during oral glucose tolerance test and hemoglobin A1c (HbA1c) in 276 consecutive Fontan patients (aged 19 ± 7 years). Of these, 176 patients had serial AGM assessments with a mean interval of 6.5 years.
Results |
Initial analysis revealed a high prevalence of impaired glucose tolerance (38.4%) and diabetes mellitus (DM) (4.7%), and positive family history, high HbA1c, and high central venous pressure independently predicted presence of DM. HbA1c was independently determined by hypersplenism and presence of DM (P < .05). Serial assessments revealed an increased PG-spike and a decreased HbA1c (P < .001 for both). Prevalence of DM increased (6.3% to 10.3%), and positive family history, high liver enzymes, and AGM predicted new onset of DM (P < .05 for all). Twenty-one patients died during 7.1-year follow-up. FPG (P < .01) and PG-spike (P < .05) independently predicted all-cause mortality. Particularly, patients with FPG ≤ 74 and/or PG-spike ≥85 had a mortality rate 8.7 times higher than those without (P = .0129).
Conclusions |
AGM progressed even in young adult Fontan patients, and HbA1c showed limited predictive value for progression. Oral glucose tolerance test plays important roles in uncovering unique Fontan AGM as well as predicting all-cause mortality.
Le texte complet de cet article est disponible en PDF.Plan
Vol 216
P. 125-135 - octobre 2019 Retour au numéro
Article précédent
- Direct oral anticoagulant– versus vitamin K antagonist–related gastrointestinal bleeding: Insights from a nationwide cohort
- Jawad H. Butt, Ang Li, Ying Xian, Eric D. Peterson, David Garcia, Christian Torp-Pedersen, Lars Køber, Emil L. Fosbøl
- Identification, diagnosis, treatment, and in-hospital outcomes of acute pulmonary embolism: Results from a single integrated health system
- Tara Holder, Alexander E. Sullivan, Tracy Truong, Manesh R. Patel, Olamiji Sofela, Cynthia L. Green, Talal Dahhan, W. Schuyler Jones
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?